Wordt geladen...
Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients
The purpose of this pilot study was to determine whether blood-borne microvesicles from newly diagnosed glioblastoma patients could be used as biomarkers. We collected 2.8 mL blood from 16 post-operative patients at the time that they were being simulated for chemoradiation therapy (radiation with c...
Bewaard in:
Gepubliceerd in: | J Neurooncol |
---|---|
Hoofdauteurs: | , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
2016
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4783260/ https://ncbi.nlm.nih.gov/pubmed/26746692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-015-2051-3 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|